Dogwood Therapeutics Stock Performance
as on September 22, 2026 at 6:59 am IST
Day's Low
Day's High
$1.58$1.73
2.47%
Downside
6.79%
Upside

52 Week's Low
52 Week's High
$1.28$9.50
20.99%
Downside
486.42%
Upside

Dogwood Therapeutics share price movements today
- Previous Close
- $1.69
- Open
- $1.73
- Volume
- 193.4K
- Market Cap
- $57.4M
- Day's Low - High
- $1.58 - $1.73
- 52 Week Low - High
- $1.28 - $9.50
Dogwood Therapeutics Historical Returns
- 1 Month Return
- -32.13 %
- 3 Month Return
- + 9.03 %
- 1 Year Return
- -66.27 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Dogwood Therapeutics Stock Fundamentals & Key Indicators
Check Dogwood Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$57.4M
EPS (TTM)
-8.95
Dividend Yield
0.00%
PE Ratio (TTM)
-0.19
Industry PE ratio
-2.34
PEG Ratio
-0.005225054267356013
Return On Equity TTM
-47.85%
Dogwood Therapeutics Stock Valuation
Track how Dogwood Therapeutics P/E has moved over time to understand its valuation trends.
Dogwood Therapeutics in the last 5 years
Lowest (-2.67x)
December 31, 2021
Industry (-2.34x)
December 31, 2025
Today (-0.96x)
December 31, 2025
Highest (-0.21x)
March 31, 2025
Today’s Price to Earnings Ratio: -0.96x
Dogwood Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dogwood Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $57.4M | NA | -0.19 | 0.00% | 0.00% | |
| Neutral | $61.5B | -64.51% | -19.3 | -12.57% | 0.00% | |
| StrongBuy | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| Buy | $80.8B | 21.32% | 18.48 | 84.86% | 0.47% |
Stock Returns calculator for Dogwood Therapeutics Stock including INR - Dollar returns
The Dogwood Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Dogwood Therapeutics investment value today
Current value as on today
₹35,082
Returns
Returns from Dogwood Therapeutics Stock
Dollar Impact
₹2,747 (+2.75%)
Analyst Recommendation on Dogwood Therapeutics Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Dogwood Therapeutics. Average target price of $13.5
Indian Investors' Interest in Dogwood Therapeutics Stock
Search interest for Dogwood Therapeutics Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:71% versus previous 30 day period
Dogwood Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Dogwood Therapeutics Annual Profit & Loss
All numbers in Millions USD
Dogwood Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Dogwood Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Dogwood Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 3 years, Moderna, Inc. Common Stock has given 53.7% return, outperforming this stock by 146.5%
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 576.6%
NEGATIVE IMPACTPrice Dip

In the last 7 days, DWTX stock has moved down by -8.4%
About Dogwood Therapeutics
| Organisation | Dogwood Therapeutics |
| Headquarters | 44 Milton Avenue, Alpharetta, GA, 30009, US |
| Industry | Biotechnology |
| CEO | Gregory Duncan |
| E-voting on shares | Click here to vote |
Key Management of Dogwood Therapeutics
Name | Title |
|---|---|
Ms. Angela Walsh | CFO, Secretary & Treasurer |
Dr. R. Michael Gendreau M.D., Ph.D. | Chief Medical Officer |
Dr. William L. Pridgen M.D. | Founder & Member of Scientific Advisory Board |
Mr. Ralph D. Grosswald M.P.H. | Senior Vice President of Operations |
Ms. Carol Duffy Ph.D. | Chief Scientific Advisor |
Mr. Gregory Duncan | Chairman & CEO |
FAQs
What is Dogwood Therapeutics share price today?
Dogwood Therapeutics share price today is $1.62 as on at the close of the market. Dogwood Therapeutics share today touched a day high of $1.73 and a low of $1.58.
What is the 52 week high and 52 week low for Dogwood Therapeutics share?
Dogwood Therapeutics share touched a 52 week high of $9.50 on and a 52 week low of $1.28 on . Dogwood Therapeutics stock price today i.e. is closed at $1.62,which is 82.95% down from its 52 week high and 26.56% up from its 52 week low.
What is Dogwood Therapeutics's market capitalisation today?
Dogwood Therapeutics market capitalisation is $0.00T as on .
How to invest in Dogwood Therapeutics Stock (DWTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Dogwood Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dogwood Therapeutics Shares that will get you 0.9259 shares as per Dogwood Therapeutics share price of $1.62 per share as on September 22, 2026 at 1:29 am IST.
What is the minimum amount required to buy Dogwood Therapeutics Stock (DWTX) from India?
Indian investors can start investing in Dogwood Therapeutics (DWTX) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Dogwood Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dogwood Therapeutics share’s latest price of $1.62 as on September 22, 2026 at 1:29 am IST, you will get 6.1728 shares of Dogwood Therapeutics. Learn more about
fractional shares .